Detalhe da pesquisa
1.
Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation Therapy.
Int J Mol Sci
; 23(20)2022 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36293222
2.
Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study.
J Nucl Med
; 65(2): 236-244, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38164576
3.
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
NPJ Breast Cancer
; 10(1): 4, 2024 Jan 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38184611
4.
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.
Cancers (Basel)
; 15(8)2023 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37190261
5.
Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment option.
World J Nucl Med
; 20(3): 316-318, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34703403
6.
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines.
Nucl Med Biol
; 96-97: 68-79, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33839677
7.
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors.
Nat Cancer
; 2(6): 611-628, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35121941
8.
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle.
Clin Pharmacol Ther
; 106(1): 148-163, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30107040
9.
A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.
Phys Med
; 56: 41-49, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30527088
10.
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy.
EJNMMI Phys
; 4(1): 7, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28127694
11.
N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging.
Oncotarget
; 8(34): 56185-56198, 2017 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-28915583
12.
Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2.
J Nucl Med
; 57 Suppl 1: 81S-8S, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26834107
13.
Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.
Mol Imaging Biol
; 17(5): 697-703, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25761907